JP2001506749A5 - - Google Patents

Download PDF

Info

Publication number
JP2001506749A5
JP2001506749A5 JP1998524275A JP52427598A JP2001506749A5 JP 2001506749 A5 JP2001506749 A5 JP 2001506749A5 JP 1998524275 A JP1998524275 A JP 1998524275A JP 52427598 A JP52427598 A JP 52427598A JP 2001506749 A5 JP2001506749 A5 JP 2001506749A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998524275A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001506749A (ja
JP3958797B2 (ja
Filing date
Publication date
Priority claimed from DE19649389A external-priority patent/DE19649389A1/de
Application filed filed Critical
Publication of JP2001506749A publication Critical patent/JP2001506749A/ja
Publication of JP2001506749A5 publication Critical patent/JP2001506749A5/ja
Application granted granted Critical
Publication of JP3958797B2 publication Critical patent/JP3958797B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP52427598A 1996-11-29 1997-11-26 抗原特異的IgM検出 Expired - Lifetime JP3958797B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19649389.7 1996-11-29
DE19649389A DE19649389A1 (de) 1996-11-29 1996-11-29 Antigenspezifischer IgM-Nachweis
PCT/EP1997/006583 WO1998023955A2 (de) 1996-11-29 1997-11-26 ANTIGENSPEZIFISCHER IgM-NACHWEIS

Publications (3)

Publication Number Publication Date
JP2001506749A JP2001506749A (ja) 2001-05-22
JP2001506749A5 true JP2001506749A5 (enExample) 2005-04-07
JP3958797B2 JP3958797B2 (ja) 2007-08-15

Family

ID=7813066

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52427598A Expired - Lifetime JP3958797B2 (ja) 1996-11-29 1997-11-26 抗原特異的IgM検出

Country Status (18)

Country Link
US (1) US6489129B1 (enExample)
EP (1) EP0944832B1 (enExample)
JP (1) JP3958797B2 (enExample)
KR (1) KR20000057315A (enExample)
CN (1) CN1245560A (enExample)
AR (1) AR009638A1 (enExample)
AT (1) ATE204082T1 (enExample)
AU (1) AU720123B2 (enExample)
BR (1) BR9714365A (enExample)
CA (1) CA2272302A1 (enExample)
DE (2) DE19649389A1 (enExample)
ES (1) ES2162347T3 (enExample)
IL (1) IL130112A0 (enExample)
NO (1) NO992579L (enExample)
NZ (1) NZ335754A (enExample)
TW (1) TW434405B (enExample)
WO (1) WO1998023955A2 (enExample)
ZA (1) ZA9710726B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7387890B2 (en) * 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ATE516298T1 (de) * 2007-04-20 2011-07-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
CN102507932A (zh) * 2011-12-02 2012-06-20 无锡博慧斯生物医药科技有限公司 一种IgM抗体检测试纸条
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
ES2906853T3 (es) 2014-04-02 2022-04-20 Chembio Diagnostic Systems Inc Inmunoensayo que utiliza conjugado de atrapamiento
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
CN105759059A (zh) * 2016-04-27 2016-07-13 丹娜(天津)生物科技有限公司 一种检测EV71病毒IgM抗体的免疫检测试剂盒及其制备方法
CN105974111B (zh) * 2016-07-20 2019-07-09 国家纳米科学中心 一种类风湿因子(IgM型)及其他抗原特异性IgM抗体联合检测的方法
CN107656057A (zh) * 2017-09-06 2018-02-02 中国农业科学院兰州兽医研究所 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用
JP7198932B2 (ja) * 2018-09-18 2023-01-04 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド ジカウイルスイムノアッセイの方法および試薬
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒
CN119505004B (zh) * 2023-08-22 2026-02-24 重庆艾生斯生物工程有限公司 抗rf的抗体或其功能性片段及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
WO1996003652A1 (de) 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
US5804371A (en) * 1994-07-25 1998-09-08 Boehringer Mannheim Gmbh Hapten-labelled peptides
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz

Similar Documents

Publication Publication Date Title
JP2001504279A5 (enExample)
JP2001506845A5 (enExample)
JP2000505629A5 (enExample)
JP2000507714A5 (enExample)
JP2000504949A5 (enExample)
JP2000507577A5 (enExample)
JP2000507756A5 (enExample)
JP2000504524A5 (enExample)
JP2000508601A5 (enExample)
JP2000503235A5 (enExample)
JP2000506650A5 (enExample)
JP2000504267A5 (enExample)
JP2000507463A5 (enExample)
JP2000508675A5 (enExample)
JP2000506134A5 (enExample)
JP2000504115A5 (enExample)
JP2000505356A5 (enExample)
JP2000503321A5 (enExample)
JP2000506890A5 (enExample)
JP2000500857A5 (enExample)
JP2000506160A5 (enExample)
JP2000505297A5 (enExample)
JP2001501170A5 (enExample)
JP2000506864A5 (enExample)
JP2000503463A5 (enExample)